Mechanism/effect boundary: in a small pilot (n=8 healthy men), acute and one-week oral supplementation with 10 mg/day boron increased plasma boron concentration and was associated with changes in steroid hormones (increased free testosterone, decreased estradiol) and reduced inflammatory biomarkers (hsCRP, TNF-alpha); this is a small, non-placebo-controlled preliminary study, not a validated dose-response finding.
Acute supplementation with 11.6 mg of boron resulted in a significant increase in plasma boron concentration.
Evidence scope. Human, oral, n=8 healthy men only, small non-placebo-controlled pilot (acute + 1 week duration) — not a large or controlled trial; the 11.6 mg figure belongs to a different, uncited source.